KIMBERLY SCHMID: Open Payments
NPI 1619990918 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 23 payments from 11 companies in 2025. Trend: 2023 $199 · 2024 $307 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| PFIZER INC. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| Novo Nordisk Inc | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Biogen, Inc. | 1 | $15 |
Products named: AIRSUPRA, FARXIGA, PREVNAR 20, CAPLYTA, REXULTI, ROTATEQ, MOUNJARO, EVENITY.
Industry payments across KS — which companies pay providers there.
